PPP1R15B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.282400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.030600E-01
Normal-vs-Stage2
4.862400E-01
Normal-vs-Stage3
4.834200E-01
Normal-vs-Stage4
6.044100E-02
Stage1-vs-Stage2
7.949200E-01
Stage1-vs-Stage3
9.582300E-02
Stage1-vs-Stage4
1.012380E-01
Stage2-vs-Stage3
1.411800E-01
Stage2-vs-Stage4
3.056400E-02
Stage3-vs-Stage4
7.276600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.441600E-01
Normal-vs-AfricanAmerican
3.176000E-01
Normal-vs-Asian
6.223600E-01
Caucasian-vs-AfricanAmerican
3.686600E-01
Caucasian-vs-Asian
9.073400E-01
AfricanAmerican-vs-Asian
5.788200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.996600E-01
Normal-vs-Female
5.678800E-01
Male-vs-Female
3.135400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.928800E-01
Normal-vs-Age(41-60Yrs)
3.609000E-01
Normal-vs-Age(61-80Yrs)
6.073600E-01
Normal-vs-Age(81-100Yrs)
8.738600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.596800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.873800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.961600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.798200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.258970E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.603800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.678200E-01
Normal-vs-Daily Drinker
8.919000E-01
Normal-vs-Weekly Drinker
7.667600E-01
Normal-vs-Occasional Drinker
4.164000E-01
Normal-vs-Social Drinker
7.059200E-01
Non Drinker-vs-Daily Drinker
3.188600E-01
Non Drinker-vs-Weekly Drinker
7.577000E-01
Non Drinker-vs-Occasional Drinker
5.586600E-01
Non Drinker-vs-Social Drinker
6.829000E-01
Daily Drinker-vs-Weekly Drinker
6.583800E-01
Daily Drinker-vs-Occasional Drinker
1.467370E-01
Daily Drinker-vs-Social Drinker
6.348400E-01
Weekly Drinker-vs-Occasional Drinker
4.836600E-01
Weekly Drinker-vs-Social Drinker
9.682000E-01
Occasional Drinker-vs-Social Drinker
3.799200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.114100E-02
Normal-vs-Grade 2
8.258800E-03
Normal-vs-Grade 3
6.435800E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.798220E-02
Grade 1-vs-Grade 3
5.492100E-02
Grade 1-vs-Grade 4
6.114100E-02
Grade 2-vs-Grade 3
6.748400E-01
Grade 2-vs-Grade 4
8.258800E-03
Grade 3-vs-Grade 4
6.435800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.221200E-01
Normal-vs-NonDiabetic
6.014000E-01
Diabetic-vs-NonDiabetic
6.319600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.665200E-01
Normal-vs-NoPancreatitis
6.100800E-01
Pancreatitis-vs-NoPancreatitis
9.409400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.094800E-01
Normal-vs-N1
5.148800E-01
N0-vs-N1
9.065400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.396800E-01
Normal-vs-TP53-NonMutant
7.146200E-01
TP53-Mutant-vs-TP53-NonMutant
3.986200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
